Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2883786734;86735;86736 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
N2AB2719681811;81812;81813 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
N2A2626979030;79031;79032 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
N2B1977259539;59540;59541 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
Novex-11989759914;59915;59916 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
Novex-21996460115;60116;60117 chr2:178559623;178559622;178559621chr2:179424350;179424349;179424348
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Ig-144
  • Domain position: 83
  • Structural Position: 171
  • Q(SASA): 0.5746
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/S None None 0.992 N 0.492 0.245 0.335661160332 gnomAD-3.1.2 6.57E-06 None None None None N None 2.41E-05 0 0 0 0 None 0 0 0 0 0
T/S None None 0.992 N 0.492 0.245 0.335661160332 gnomAD-4.0.0 6.56763E-06 None None None None N None 2.40616E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1214 likely_benign 0.1239 benign -0.555 Destabilizing 0.767 D 0.343 neutral N 0.482265364 None None N
T/C 0.51 ambiguous 0.5588 ambiguous -0.367 Destabilizing 1.0 D 0.725 prob.delet. None None None None N
T/D 0.6078 likely_pathogenic 0.5964 pathogenic 0.289 Stabilizing 1.0 D 0.763 deleterious None None None None N
T/E 0.5811 likely_pathogenic 0.5737 pathogenic 0.246 Stabilizing 1.0 D 0.736 prob.delet. None None None None N
T/F 0.2975 likely_benign 0.3098 benign -0.886 Destabilizing 1.0 D 0.799 deleterious None None None None N
T/G 0.3408 ambiguous 0.3541 ambiguous -0.739 Destabilizing 0.997 D 0.691 prob.neutral None None None None N
T/H 0.3288 likely_benign 0.3423 ambiguous -0.988 Destabilizing 1.0 D 0.779 deleterious None None None None N
T/I 0.2299 likely_benign 0.2509 benign -0.18 Destabilizing 0.999 D 0.768 deleterious D 0.536638567 None None N
T/K 0.5177 ambiguous 0.5119 ambiguous -0.438 Destabilizing 1.0 D 0.731 prob.delet. None None None None N
T/L 0.145 likely_benign 0.1497 benign -0.18 Destabilizing 0.997 D 0.639 neutral None None None None N
T/M 0.1014 likely_benign 0.1048 benign -0.018 Destabilizing 1.0 D 0.729 prob.delet. None None None None N
T/N 0.1413 likely_benign 0.1476 benign -0.294 Destabilizing 1.0 D 0.695 prob.neutral N 0.498946971 None None N
T/P 0.1429 likely_benign 0.1249 benign -0.274 Destabilizing 0.999 D 0.775 deleterious N 0.492773582 None None N
T/Q 0.3368 likely_benign 0.3372 benign -0.472 Destabilizing 1.0 D 0.762 deleterious None None None None N
T/R 0.464 ambiguous 0.457 ambiguous -0.197 Destabilizing 1.0 D 0.771 deleterious None None None None N
T/S 0.1181 likely_benign 0.1217 benign -0.574 Destabilizing 0.992 D 0.492 neutral N 0.455558766 None None N
T/V 0.175 likely_benign 0.1882 benign -0.274 Destabilizing 0.997 D 0.535 neutral None None None None N
T/W 0.7253 likely_pathogenic 0.7374 pathogenic -0.847 Destabilizing 1.0 D 0.771 deleterious None None None None N
T/Y 0.3771 ambiguous 0.3886 ambiguous -0.582 Destabilizing 1.0 D 0.794 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.